Astragaloside IV attenuates complement membranous attack complex induced podocyte injury through the MAPK pathway

Phytotherapy Research

Volumn 26, Issue 6, 2012, Pages 892-898

  Zheng, Rong ^a   Deng, Yueyi ^a   Chen, Yiping ^a   Fan, Junming ^b   Zhang, Minghua ^b   Zhong, Yifei ^a   Zhu, Rong ^a   Wang, Lin ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Astragaloside IV; complement; MAP kinase; membranous nephropathy; podocytes

Indexed keywords

ASTRAGALOSIDE IV; COMPLEMENT MEMBRANE ATTACK COMPLEX; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STRESS ACTIVATED PROTEIN KINASE; ZYMOSAN;

ANIMAL CELL; ARTICLE; ASTRAGALUS MEMBRANACEUS; CELL DAMAGE; CELL LOSS; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; DRUG EFFICACY; DRUG MECHANISM; ENZYME PHOSPHORYLATION; ENZYME RELEASE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MEMBRANOUS GLOMERULONEPHRITIS; MOUSE; NONHUMAN; PATHOGENESIS; PODOCYTE; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; WESTERN BLOTTING;

ACTIN CYTOSKELETON; ANIMALS; ASTRAGALUS MEMBRANACEUS; CELL LINE; COMPLEMENT MEMBRANE ATTACK COMPLEX; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; GLOMERULONEPHRITIS, MEMBRANOUS; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; L-LACTATE DEHYDROGENASE; MAP KINASE SIGNALING SYSTEM; MICE; PHOSPHORYLATION; PODOCYTES; PROTECTIVE AGENTS; PROTEINURIA; SAPONINS; TIME FACTORS; TRITERPENES;

ASTRAGALUS MEMBRANACEUS;

EID: 84861825840     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3656     Document Type: Article

References (43)

1. Adler S, Baker PJ, Johnson RJ, Ochi RF, Pritzl P, Couser WG,. 1986. Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest 77: 762-767.
2. Bradamante S, Villa A, Versari S, Barenghi L, Orlandi I, Vai M,. 2010. Oxidative stress and alterations in actin cytoskeleton trigger glutathione efflux in Saccharomyces cerevisiae. Biochim Biophys Acta 1803: 1376-1385.
3. Cai Q, Li X, Wang H,. 2001. Astragali and Angelica protect the kidney against ischemia and reperfusion injury and accelerate recovery. Chin Med J (Engl) 114: 119-123.
4. Cui XL, Douglas JG,. 1997. Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells. Proc Natl Acad Sci U S A 94: 3771-3776.
5. Cuzzocrea S, Zingarelli B, Calapai G, Nava F, Caputi AP,. 1997. Zymosan-activated plasma induces paw oedema by nitric oxide and prostaglandin production. Life Sci 60: 215-220.
6. Cybulsky AV, Monge JC, Papillon J, McTavish AJ,. 1995. Complement C5b-9 activates cytosolic phospholipase A2 in glomerular epithelial cells. Am J Physiol 269: F739-749.
7. Cybulsky AV, Papillon J, McTavish AJ,. 1998. Complement activates phospholipases and protein kinases in glomerular epithelial cells. Kidney Int 54: 360-372.
8. Cybulsky AV, Quigg RJ, Salant DJ,. 2005. Experimental membranous nephropathy redux. Am J Physiol Renal Physiol 289: F660-671.
9. Cybulsky AV, Takano T, Papillon J, Khadir A, Bijian K, Le Berre L,. 2004. The actin cytoskeleton facilitates complement-mediated activation of cytosolic phospholipase A2. Am J Physiol Renal Physiol 286: F466-476.
10. Cybulsky AV, Takano T, Papillon J, Khadir A, Liu J, Peng H,. 2002. Complement C5b-9 membrane attack complex increases expression of endoplasmic reticulum stress proteins in glomerular epithelial cells. J Biol Chem 277: 41342-41351.
11. Cybulsky AV, Takano T, Papillon J, McTavish AJ,. 1999. Complement C5b-9 induces receptor tyrosine kinase transactivation in glomerular epithelial cells. Am J Pathol 155: 1701-1711.
12. Gao WZ, Kang Y, Lou JS,. 2005. Protective effects of astragaloside IV on free redical injury induced by adriamycin in myocardium rats. Chin J Cardio Med 10: 166-169.
13. Garcia de Yebenes J, Yebenes J, Mena MA,. 2000. Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease. Neurotox Res 2: 115-137.
14. Glassock RJ,. 2003. Diagnosis and natural course of membranous nephropathy. Semin Nephrol 23: 324-332.
15. Guan HL, Wei Sun, Shijie Yang,. 2007. Protective effects of Astragaloside IV on hydrogen peroxide-induced injury of cultured neonatal rat myocardial cells. J Jilin Univ (Med Edn) 2: 211-214.
16. Hu JY, Han J, Chu ZG, et al,. 2009. Astragaloside IV attenuates hypoxia-induced cardiomyocyte damage in rats by upregulating superoxide dismutase-1 levels. Clin Exp Pharmacol Physiol 36: 351-357.
17. Ishikawa S, Tsukada H, Bhattacharya J,. 1993. Soluble complex of complement increases hydraulic conductivity in single microvessels of rat lung. J Clin Invest 91: 103-109.
18. Kerjaschki D, Neale TJ,. 1996. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis). J Am Soc Nephrol 7: 2518-2526.
19. Ko JK, Lam FY, Cheung AP,. 2005. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol 11: 5787-5794.
20. Li X, He D, Zhang L, Cheng X, Sheng B, Luo Y,. 2006. Anovel antioxidant agent, astragalosides, prevents shock wave-induced renal oxidative injury in rabbits. Urol Res 34: 277-282.
21. Li ZP, Cao Q,. 2002. Effects of astragaloside IV on myocardial calcium transport and cardiac function in ischemic rats. Acta Pharmacol Sin 23: 898-904.
22. Luo Y, Qin Z, Hong Z, et al,. 2004. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia. Neurosci Lett 363: 218-223.
23. .OH. Zhong Yao Cai 22: 303-306.
24. Mundel P, Reiser J, Zuniga Mejia Borja A, et al,. 1997. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248-258.
25. Mundel P, Shankland SJ,. 2002. Podocyte biology and response to injury. J Am Soc Nephrol 13: 3005-3015.
26. Nangaku M, Shankland SJ, Couser WG,. 2005. Cellular response to injury in membranous nephropathy. J Am Soc Nephrol 16: 1195-1204.
27. Neale TJ, Ullrich R, Ojha P, Poczewski H, Verhoeven AJ, Kerjaschki D,. 1993. Reactive oxygen species and neutrophil respiratory burst cytochrome b558 are produced by kidney glomerular cells in passive Heymann nephritis. Proc Natl Acad Sci U S A 90: 3645-3649.
28. Ni Z, Zhang Q, Qian J, Wang L,. 1999. Effect of Astragalin on matrix secretion and beta 1 integrin mRNA expression in human mesangial cells. Chin Med J (Engl) 112: 1063-1067.
29. Okamoto K, Wang W, Rounds J, Chambers E, Jacobs DO,. 2000. Sublytic complement attack increases intracellular sodium in rat skeletal muscle. J Surg Res 90: 174-182.
30. Peng H, Takano T, Papillon J, Bijian K, Khadir A, Cybulsky AV,. 2002. Complement activates the c-Jun N-terminal kinase/stress-activated protein kinase in glomerular epithelial cells. J Immunol 169: 2594-2601.
31. Rios JL, Waterman PG,. 1997. Areview of the pharmacology and toxicology of Astragalus. Phytother Res 11: 411-418.
32. Ronco P, Debiec H,. 2005. Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization. J Am Soc Nephrol 16: 1205-1213.
33. Schonermark M, Deppisch R, Riedasch G, Rother K, Hansch GM,. 1991. Induction of mediator release from human glomerular mesangial cells by the terminal complement components C5b-9. Int Arch Allergy Appl Immunol 96: 331-337.
34. Shah SV,. 1988. Evidence suggesting a role for hydroxyl radical in passive Heymann nephritis in rats. Am J Physiol 254: F337-344.
35. Sinclair S,. 1999. Migraine headaches: nutritional, botanical and other alternative approaches. Altern Med Rev 4: 86-95.
36. Somlo S, Mundel P,. 2000. Getting a foothold in nephrotic syndrome. Nat Genet 24: 333-335.
37. Takano T, Cybulsky AV, Yang X, Aoudjit L,. 2001. Complement C5b-9 induces cyclooxygenase-2 gene transcription in glomerular epithelial cells. Am J Physiol Renal Physiol 281: F841-850.
38. Tedesco F, Pausa M, Nardon E, Introna M, Mantovani A, Dobrina A,. 1997. The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J Exp Med 185: 1619-1627.
39. Topham PS, Haydar SA, Kuphal R, Lightfoot JD, Salant DJ,. 1999. Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesions. Kidney Int 55: 1763-1775.
40. Torbohm I, Schonermark M, Wingen AM, Berger B, Rother K, Hansch GM,. 1990. C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells. Kidney Int 37: 1098-1104.
41. Tryggvason K, Pikkarainen T, Patrakka J,. 2006. Nck links nephrin to actin in kidney podocytes. Cell 125: 221-224.
42. Wasserstein AG,. 1997. Membranous glomerulonephritis. J Am Soc Nephrol 8: 664-674.
43. Wojcikowski K, Johnson DW, Gobe G,. 2006. Herbs or natural substances as complementary therapies for chronic kidney disease: ideas for future studies. J Lab Clin Med 147: 160-166.